• About
  • Subscribe
  • Advertise
  • Contact
Friday, January 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Ophthalmic insights Policy & regulation

Ahpra fee model leads to unfair charges, Ombudsman finds

by Staff Writer
December 2, 2025
in Ahpra/National Boards, Local, News, Ophthalmic insights, Policy & regulation
Reading Time: 3 mins read
A A
The report follows complaints from three registered practitioners. Image: Worawi/stock.adobe.com

The report follows complaints from three registered practitioners. Image: Worawi/stock.adobe.com

Share on FacebookShare on Twitter

The way national health practitioner registration fees are charged can deliver unfair financial outcomes for clinicians who register outside their profession’s standard renewal cycle, an investigation by the National Health Practitioner Ombudsman has found.

Published on 27 November by Ombudsman Ms Richelle McCausland, the report follows complaints from three registered practitioners who were required to pay fees to the Australian Health Practitioner Regulation Agency (Ahpra) twice within just three months.

The findings show that the rigidity of set annual renewal dates – a requirement under the Health Practitioner Regulation National Law – can leave some clinicians paying thousands in rapid succession.

In one example examined by the investigation, a medical practitioner who paid application and registration fees in July was required to pay their renewal fee again by 30 September of the same year. The combined fees in that case totalled around $3,600, within a 12-week period.

The investigation identified that clinicians taking or returning from parental leave, first-time registrants, and those changing their registration type were more likely to be financially disadvantaged by the current fee approach.

It also uncovered errors and inconsistencies in publicly available information. The Ombudsman acknowledged Ahpra’s removal of previously published material during the investigation which had incorrectly stated that the national law does not allow fees to be pro-rated or partially refunded.

Not all the developments were negative. The Ombudsman pointed to improvements announced by Ahpra during the inquiry, including the start of a 30 per cent rebate on annual fees for practitioners taking parental leave or other protected leave from 1 July 2025, along with the commencement of a broader review into its pro-rata fees strategy. Ahpra has formally accepted the Ombudsman’s suggestions for improvement, and its written response is now attached to the published report.

The Health Chief Executives Forum has noted the findings.

“Health practitioners are facing financial and cost-of-living pressures like many community members, and they need to have confidence that the registration fees they are charged are fair and reasonable,” Ms McCausland said.

“It is necessary for Ahpra and the national boards to charge registration fees and this is enabled by the relevant law. But the way fees are charged must be fair,” she said, welcoming both the removal of inaccurate public information and the agency’s acceptance of further reform suggestions.

The Ombudsman’s first recommendation asks that the Pro Rata Fee Review factor in the investigation’s findings, including transparency, consistency, cost-recovery evidence, and fee waiver or reimbursement pathways where appropriate. The second recommendation calls for a comprehensive update of all public-facing information on fee charging models to ensure accuracy across professions and registration categories.

Related Posts

The study concluded that clinicians should be aware of how cognitive limitations can lead to a reliance on "decisional shortcuts" that might bias decision-making. Image: rh2010/stock.adobe.com

Study supports rethink of IOP threshold in glaucoma treatment

by Staff Writer
January 16, 2026

New research has revealed that despite an evolving clinical understanding of glaucoma, many ophthalmologists continue to rely on the historical...

optometrists cyber-crimes

Smart glasses market tipped to hit $200b by 2040

by Rob Mitchell
January 16, 2026

Financial analysts are predicting rapid growth of the smart glasses market, with one global eyewear giant predicted to potentially double...

Sophi is an eco-conscious phaco system. Image: Rayner.

FDA clears Rayner’s Sophi device for US market

by Staff Writer
January 15, 2026

British ophthalmic equipment manufacturer Rayner has secured US Food and Drug Administration (FDA) clearance for Sophi, its Swiss-engineered phacoemulsification system....

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited